SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - (GEM) PRINTED: 09/10/00 PAGE: 1 DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B (GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS) STOCK NAME : Sino Biopharm (08027) Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration ------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- TSE PING E ORD SINO BIOPHARMACEUTICAL LIMITED 9,000,000 N1 - - 0 ***** END OF REPORT ***** Note: N1 9,000,000 shares were borrowed by DBS Asia Capital Limited under stock borrowing arrangement for settlement of over-allocation in connection with placing on initial listing of the Company. |